Novavax’s 1st-stage coronavirus vaccine study finds all volunteers developed viral antibodies
Biotech company Novavax publishes study which finds all volunteers for phase 1 coronavirus trial have developed viral antibodies
Biotech company Novavax publishes study which finds all volunteers for phase 1 coronavirus trial have developed viral antibodies